For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230303:nRSC9177Ra&default-theme=true
RNS Number : 9177R Craven House Capital PLC 03 March 2023
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK
VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH
LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON
PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS
INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
Craven House Capital plc
Portfolio Update
Craven House Capital plc ("Craven House" or the "Company"), the AIM quoted
investment company provides this update regarding the following investee
companies:
Stormfjord Ltd ("Stormfjord")
The Company has been informed that Stormfjord, the owner of www.onebas.com
raised $100,000 on 1st March 2023 at a valuation of $28,000,000.
Craven House originally acquired a 29.9% stake in Onebas.com Ltd (the previous
legal entity under which the domain Onebas.com was owned) on 13 March 2020 for
a consideration of $1,600,000 via a share subscription for 800,000 ordinary
shares in the Company priced at $10.00 per share. This valued Onebas.com Ltd
at $5.35m.
Following completion of the fundraising, Craven House's holding of 29,900,000
shares represents 25.5% of Stomfjord.
Rosedog Ltd ("Rosedog")
The Company has been informed that Rosedog, the owner of www.tvzinos.com
raised $70,000 on 1st March 2023 at a valuation of $28,000,000.
Craven House originally acquired a 29.9% stake in Rosedog on 13 March 2020 for
a consideration of $1,600,000 via a share subscription for 800,000 ordinary
shares in the Company priced at $10.00 per share. This valued Rosedog Ltd at
$5.35m.
Following completion of the fundraising, Craven House's holding of 29,900,000
shares represents 28.6% of Rosedog.
Bio Vitos Ltd ("Bio Vitos")
The Company has been informed that Bio Vitos raised $13,000 on 1st March 2023,
at a valuation of $10,000,000.
Craven House originally acquired a 29.9% stake in Bio Vitos (previously called
YRRO Ltd) on 13 March 2020 for a consideration of $1,600,000 via a share
subscription for 800,000 ordinary shares in the Company priced at $10.00 per
share. This valued Bio Vitos at $5.35m.
Following completion of the fundraising, Craven House's holding of 14,708,700
shares represents 24.5% of Bio Vitos.
~ Ends ~
For further information please contact:
Craven House Capital Plc Tel: 0203 286 8130
Mark Pajak
www.Cravenhousecapital.com (http://www.Cravenhousecapital.com)
Tel: 0203 286 8130
SI Capital Tel: 01483 413500
Broker
Nick Emerson
www.sicapital.co.uk
SPARK Advisory Partners Limited Tel: 0203 368 3550
Nominated Adviser
Matt Davis/James Keeshan
www.Sparkadvisorypartners.com
About Craven House Capital plc: The Company's Investing Policy is primarily to
invest in or acquire a portfolio of companies, partnerships, joint ventures,
businesses or other assets participating in the e-Commerce sector.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END PFUBIGDXSBGDGXX